Index
Aber, Cynthia S., 225n.3, 230n.56
abjection, 224n.142
Adler, Alfred, 22
advertisements, pharmaceutical, 127–
63; and anxiety, 155–63; 156, 159–62;
anxiety created by, 132, 134, 135, 145,
148, 226–27n.16; Buspar ads, 155;
Deprol ads, 42, 44, 128–29, 134–43,
148, 150, 211n.58; dtc (direct-to-
consumer) ads, 132, 160, 162–63,
226n.14; Effexor ads, 61, 155, 156,
233n.26; fda regulation of, 129, 162;
and feminism, 128, 131–32, 225n.3,
230n.56; Freudian assumptions per-
petuated by, 129, 158; gender divi-
sions/tensions in, 61, 62, 150, 156–57,
231n.62; Librium ads, 128–29, 139,
141; Lithobid ads, 127; Luvox ads,
155; male doctors in, 13–14, 27, 129;
and market formation/indication ex-
pansion, 230–31n.62; and marriage,
27, 129, 131–32, 135–38, 141, 142, 145,
148; Mellaril ads, 140; men as patients
in, 225n.3; Meprosan ads, 130; Mil-
town ads, 42; and momism, 137–41,
227–28nn.26–27; and motherhood,
129, 131, 159, 162; on potency, 67, 68;
and prescribing patterns of physicians,
128, 159, 162; Prozac ads, 128–29,
153–55, 161, 162–63 (see also narrative
form and Prozac: and Prozac ads);
and psychoanalytic history of wonder
drugs, 127–28; psychotropic medica-
tion as replacing male practitioners in,
56, 57–58, 211nn.57–58; psychotropic
medications as replacing psychiatry in,
211n.67; for psychotropic medications
vs. other medications, 226n.5; race in,
28–29, 30; representations of women
in, 127–29, 154, 158–59, 225nn.2–3,
230n.59, 231n.62; Sandril ads, 42;
Serax ads, 133; Sinequan ads, 142;
and social problems, 129–30; Sonata
ads, 160, 162–63; ssri ads, 131–32;
Previous Page Next Page